UNICA IRIS Institutional Research Information System

SERPE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 100.749
NA - Nord America 5.834
AS - Asia 1.940
SA - Sud America 342
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
AN - Antartide 1
Totale 108.913
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 99.172
US - Stati Uniti d'America 5.762
CN - Cina 928
SG - Singapore 670
UA - Ucraina 495
SE - Svezia 357
BR - Brasile 285
DE - Germania 247
GB - Regno Unito 163
FI - Finlandia 132
VN - Vietnam 117
KR - Corea 64
FR - Francia 59
CA - Canada 46
IN - India 26
AR - Argentina 24
RU - Federazione Russa 20
BE - Belgio 18
TR - Turchia 18
HK - Hong Kong 17
IR - Iran 16
PL - Polonia 15
ZA - Sudafrica 15
ES - Italia 13
BD - Bangladesh 12
ID - Indonesia 12
JP - Giappone 11
EC - Ecuador 10
MX - Messico 10
NL - Olanda 9
AT - Austria 8
IE - Irlanda 8
EU - Europa 7
IQ - Iraq 7
PK - Pakistan 7
RS - Serbia 7
AU - Australia 6
BG - Bulgaria 5
KE - Kenya 5
PH - Filippine 5
BO - Bolivia 4
CH - Svizzera 4
CL - Cile 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
CO - Colombia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PE - Perù 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PY - Paraguay 2
TH - Thailandia 2
UZ - Uzbekistan 2
AL - Albania 1
AQ - Antartide 1
AZ - Azerbaigian 1
BW - Botswana 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 108.913
Salva come PNG Salva come JPEG
Città #
Cagliari 97.532
Uta 1.364
Woodbridge 599
Fairfield 576
Ashburn 431
Houston 398
Dallas 397
Chandler 390
Singapore 326
Ann Arbor 316
Jacksonville 285
Nyköping 268
Boardman 250
Wilmington 249
Seattle 237
Beijing 226
Dearborn 171
Cambridge 168
Nanjing 85
Boston 79
Los Angeles 70
Hefei 68
New York 67
Santa Clara 61
Seoul 57
Shanghai 54
Helsinki 52
Ho Chi Minh City 46
San Diego 44
Nanchang 35
Buffalo 34
Munich 32
Redwood City 32
Milan 29
Changsha 28
Guangzhou 26
The Dalles 26
Toronto 24
Tianjin 23
Hanoi 22
Hebei 22
Shenyang 21
São Paulo 21
London 20
Jinan 19
Hong Kong 17
Brussels 16
Redondo Beach 16
Verona 16
Norwalk 15
Mountain View 14
Orange 14
Zhengzhou 14
Auburn Hills 13
Warsaw 13
Atlanta 12
Chicago 11
Council Bluffs 11
Jiaxing 10
Phoenix 10
Rome 10
Sassari 10
Tokyo 10
Wuhan 9
Brooklyn 8
Dong Ket 8
Rio de Janeiro 8
Augusta 7
Campinas 7
Dublin 7
Hangzhou 7
Johannesburg 7
Nuremberg 7
Nürnberg 7
San Mateo 7
Stockholm 7
Bielefeld 6
Chennai 6
Columbus 6
Denver 6
Düsseldorf 6
San Francisco 6
Winston-Salem 6
Ankara 5
Baghdad 5
Brasília 5
Charlotte 5
Curitiba 5
Frankfurt am Main 5
Leawood 5
Montreal 5
Nairobi 5
Ninh Bình 5
Poplar 5
Pune 5
Shenzhen 5
Amman 4
Amsterdam 4
Belo Horizonte 4
Bloomington 4
Totale 105.731
Salva come PNG Salva come JPEG
Nome #
High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts 4.905
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.690
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.404
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.288
Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation 3.242
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.919
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 2.735
Positive effects of Nordic Walking on anthropometric and metabolic variables in women with type 2 diabetes mellitus 2.673
Antimicrobial sulfonamides inhibit Herpesvirus 8 latency by impairing the MDM2-p53 complex formation 2.659
Sulfonamide compounds inhibit latent Human Herpesvirus 8 replication by interfering with MDM2-p53 complex formation 2.512
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.406
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 2.339
null 2.211
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.172
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.165
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.047
Validation of the CAchexia SCOre (CASCO). Staging cancer patients: The use of miniCASCO as a simplified tool 2.044
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 2.042
null 1.987
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.842
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.749
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.705
null 1.699
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.686
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.683
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.650
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.648
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia 1.645
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects 1.557
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.505
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.485
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.463
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.443
null 1.362
Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children 1.349
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.285
null 1.063
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 819
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 777
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 777
null 768
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 768
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 766
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 761
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 754
Current medications for cancer cachexia 740
Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity 723
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 709
null 709
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 702
Cancer cachexia: Physical activity and muscle force in tumour-bearing rats 701
null 694
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 676
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 670
Muscle wasting in cancer and ageing: Cachexia versus sarcopenia 664
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 662
The cachexia score (CASCO): a new tool for staging cachectic cancer patients 651
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 633
null 572
Megestrol acetate: Its impact on muscle protein metabolism supports its use in cancer cachexia 564
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 538
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 536
Antioxidant therapy for the treatment of oxidative stress associated to cancer and cancer-related anorexia/cachexia 515
Phase II study with antioxidants, both in the diet and supplemented pharmaco-nutritional support, progestagen and anti-cox-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 503
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 495
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 495
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress 488
Prevention of head and neck squamous cell carcinoma. Integrated treatment approach with diet, pharmaco-nutritional support, antioxidants, and cis-retinoic acid. A phase II study. 469
Phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS). and oxidative stress (OS) 469
Correlation between both serum osteopontin/osteonectin and bone remodelling parameters, inflammatory/metabolic variables and survival in metastatic cancer patients with tumors at different sites 469
null 465
Effects Of An Adapted Physical Training On Functional And Psycho-physical Status In Patients With Spinal Cord Injury 461
null 450
Prevention of head and neck squamous cell carcinoma. integrated treatment approach with diet, pharmaco-nutritional support, antioxidants (and anti-COX-2): preliminary results of a phase II study 434
An innovative approach to CACS 424
null 413
Randomised phase III clinical trial to evaluate the efficacy and safety of an integrated treatment (diet, pharmaco-nutrional and pharmacological) in cancer patients with cancer-related anorexia/cachexia and oxidative stress: interim results 396
Efficacy of L-carnitine administration on fatigue, quality of life and nutritional status in 12 advanced cancer patients undergoing anticancer therapy 391
null 390
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 388
null 342
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial 309
null 304
Randomised phase III clinical trial to evaluate the efficacy and safety of an integrated treatment (diet, pharmaco-nutritional and pharmacological) in cancer patients with cancer-related anorexia/cachexia and oxidative stress: Interim results 299
Impact of a two-drug combination regimen for cancer-related cachexia on nutritional, anabolic/metabolic, physical activity, anti-infammatory and quality of life variables 283
MESNA (2-mercaptoethane sulfonate) is effective in inducing lymphocyte progression through cell cycle in patients with advanced cancer of different sites 278
Curcuma Longa extract is effective in improving inflammatory status and redox balance in patients with cancer-related cachexia and oxidative stress 269
null 267
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 252
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 232
null 208
An innovative treatment approach for cancer-related anorexia/cachexia (CACS) and oxidative stress (OS). A phase III randomised clinical trial 181
Prognostic role of lipid profile in patients with advanced cancer 178
An innovative treatment approach for cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 176
null 147
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 130
Cancer related anorexia/cachexia and oxidative stress: A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 126
Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia 125
Cancer-related anorexia/cachexia (CACS) and oxidative stress (OS): A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 119
Focus on the assessment of physical activity level of patients with cancer cachexia enrolled in a randomized phase III clinical trial 111
Totale 109.044
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.094 0 0 0 0 0 2.916 2.334 1.545 579 1.152 1.027 541
2021/20224.262 401 314 179 296 465 341 175 187 353 439 550 562
2022/20235.508 491 659 689 447 465 528 254 459 355 379 464 318
2023/20246.816 445 336 335 511 693 1.312 839 473 311 467 584 510
2024/20258.457 1.040 1.647 1.329 1.267 700 1.116 564 104 185 126 184 195
2025/20262.183 300 238 677 435 347 186 0 0 0 0 0 0
Totale 109.111